ACLARIS THERAPEUTICS INC. - COMMON STOCK

Aclaris Therapeutics Provides 2023 Outlook

06 1月 2023 06:01:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agreement for ATI-1777 in Greater China

29 11月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Key Leadership Transitions

22 11月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences

10 11月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

08 11月 2022 06:00:03 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

27 9月 2022 06:00:24 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

30 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Second Quarter 2022 Financial Results and Provides a Corporate Update

03 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Expands Leadership Team

27 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference

01 6月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

16 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update

10 5月 2022 06:00:02 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium

03 5月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update

24 2月 2022 06:00:02 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference

02 2月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Expands Leadership Team

01 2月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Provides R&D Update

11 1月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference

27 12月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine

03 12月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021

18 11月 2021 15:01:00 条件 Nasdaq GlobeNewswire